Table 1.
Effects | Examples of Effects | References |
---|---|---|
Protection against ATP depletion | [2] | |
Decreased AD pathology and cognitive decline | [10] | |
Improved sensory and motor neurological behavior | [3] | |
Increased recovery from bilateral frontal brain injury | [4] | |
Neuroprotection | Prevention/delay of ischemic stroke in stroke-prone hypertensive rats | [5] |
Reduced lateral geniculate nucleus neuronal death | [6] | |
Attenuated hippocampal neuronal death after global ischemia | [7] | |
Improved motor deficits associated with Huntington’s disease phenotype | [8] | |
Increased NAD+ level and mitochondrial function | [9] | |
Amelioration of depression and psychological disorders | Amelioration of depression | [28] |
Increased social interaction | [11] | |
Anti-inflammation | Attenuated neutrophil recruitment in carrageenan-induced pleurisy or in lesions of autoimmune disease | [12,13] |
Reduced arthritis activity | [14] | |
Protection against vision and hearing loss |
Attenuated retinal pigment cell death and age-related macular degeneration in animals | [29] |
Reduced incidence of optic nerve degeneration and glaucoma | [30,31] | |
Immune modulation | Improved mouse survival after lethal Staphylococcus enterotoxin B challenge | [32] |
Skin protection/anti- skin disorders/cosmetic effects |
Downregulation of the expression of inflammatory cytokines and protection against UV light | [33] |
Anti-fibrosis | Attenuated development of pulmonary fibrosis | [34,35] |
Anti-metastasis and adjuvant cancer therapy |
Decreased growth and progression of bladder tumors | [36,37] |
Photo-protection and reduced incidence of skin cancers | [15] | |
Anti-HIV and -AIDS | Decreased provirus integration | [16] |
Decreased viral RNA expression | [17] |